Phio Pharmaceuticals Corp.
(NASDAQ : PHIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.24%171.691.3%$494.06m
BIIBBiogen Inc.
-1.13%226.521.3%$458.80m
CELGCelgene Corporation
-0.16%95.481.3%$443.76m
GILDGilead Sciences, Inc.
-0.26%67.000.9%$427.20m
ILMNIllumina, Inc.
1.56%313.793.5%$309.94m
REGNRegeneron Pharmaceuticals, Inc.
-0.64%313.232.6%$291.68m
AAgilent Technologies, Inc.
1.61%68.791.6%$213.00m
VRTXVertex Pharmaceuticals Incorporated
-0.47%172.191.9%$179.02m
EXASExact Sciences Corporation
2.97%96.7925.3%$167.87m
ALXNAlexion Pharmaceuticals, Inc.
1.68%127.442.0%$150.12m
BMRNBioMarin Pharmaceutical Inc.
2.33%89.004.3%$118.77m
INCYIncyte Corporation
1.62%81.802.5%$108.69m
SRPTSarepta Therapeutics, Inc.
2.17%120.8114.7%$106.91m
ALNYAlnylam Pharmaceuticals, Inc
1.99%69.269.2%$97.37m
IONSIonis Pharmaceuticals, Inc.
-3.78%64.608.2%$93.49m

Company Profile

Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.